Eurasian Journal of Medical Investigation
Although gallstones remain asymptomatic in about 80% of subjects, gallstone disease represents a major burden for the health systems, because of either symptomatic uncomplicated or complicated manifestations
Invega Sustenna/Xeplion/Invega Trinza/Trevicta (paliperidone) Disease area(s): Psychiatry Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $4.22 billion Why it sold so well: In 2024, J&Js long-acting antipsychotic portfolio including Invega Sustenna, Xeplion, Invega Trinza and Trevicta registered global sales of $4.22 billion, reflecting a 2.6% year-over-year increase
Most weight loss changes typically take a little longer
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (dis CoVeRy): a phase 3, randomised, controlled, open-label trial
If you have any questions about our products, please feel free to contact us: Our consultants will be happy to inform you